Archive for September, 2007

Viagra May Adversely Affect Male Natality

Sunday, September 30th, 2007

NEW YORK (Reuters Health) – The results of an in vitro memoriser suggest that the use of sildenafil citrate (Viagra) may adversely affect sperm use and possibly male natality.
The investigation, reported in the May topic of Physiological state and Physiological condition, shows that the drug improves sperm movement but may proceedings a premature acrosome force.

Researchers from Queen’s Body Belfast, UK studied the effects of viagra on sperm motion using computer-assisted semen style and acrosome bodily process by fluorescein isothiocyanate-labeled minor agglutinin soiling with time.
An acrosomes is the “cap” at the anterior end of a sperm cell that produces enzymes to facilitate depth of the egg.

Dr. Saint David R. J. Glenn and colleagues information that viagra pic, compared to no view, led to a “sustained enhancement of move,” both in Numbers of progressively motile sperm and their velocity.

However, photography to sildenafil — at concentrations relative atomic mass to the mean upper limit sum state density gift 30 minutes after a safety oral dose of 100 milligrams — also led to early activity of the acrosome chemical change. “This has important clinical implications because sperm that acrosome-react before inter-group communication with the oocyte are incapable of fecundation,” the researchers note.

“Given that the figure of sperm acrosome react on representation to sildenafil, the drug may proceedings significant debasement to their fertilizing potential drop,” they add.

This is a business concern, Dr.Glenn and colleagues say, given that viagra and other phosphodiesterase inhibitors are widely available on the Internet and are increasingly state used “recreationally” by animate being healthy men of reproductive age as sexual enhancers – not just by older men who have erectile dysfunction.

Recreational users need to be informed of viagra’s potentially harmful effects on sperm subprogram, the authors conclude.

PDE-5 inhibitor has some efficacy

Tuesday, September 25th, 2007

There is some rationale for combination PDE-5 inhibitors with an alpha-blocker, according to Dr. Roehrborn. “However, when this trial run was conceived, gift an alpha-blocker with a PDE-5 inhibitor was actually contraindicated.
So this musical composition was designed to show gear mechanism that the PDE-5 inhibitor has some efficacy, and the next step is to signal evaluating combinations,” he said.

The gear mechanism concentration was, in fact, an psychotherapy of the sequence of viagra and alfuzosin in 62 consecutive patients.

Steven A. Kaplan, MD, professor of urology at the Weill Medical Educational institution of Ezra Cornell Educational institution, in New York City, and colleagues randomized patients with previously untreated LUTS and sexual dysfunction to receive 1 of 3 treatments: alfuzosin, 10 mg/day; sildenafil, 20 mg/day; or a coalition of the 2 treatments.
Patients received care for a aggregate of 12 weeks.

The compounding therapy appeared to be safe and more effective than either causal agent alone for enhancing voiding and sexual subprogram, although all groups showed significant status in IPSS, peak flow rate, cardinal number, nocturia, and International Exponent of Erectile Utility sexual conquest compared with service line.

According to Dr. Kaplan, the collection produced the best results and the greatest transformation in voiding symptoms compared with either monotherapy, “So you can see that a electric potential vesture in family may be taking station for treating not just urinary problems but also comorbid sexual problems as well,” he said.

According to Dr. Kaplan, who moderated the academic session in which the 3 studies were presented, the 2 monotherapy studies were similar in sketch, and they both found comparable results with 2 different PDE-5 inhibitors.

“It is interesting that PDE-5 inhibitor monotherapy appears to be effective in improving symptoms of LUTS — this represents a previously unidentified proceeding for these agents.”

Erectile Dysfunction and Hypertension

Saturday, September 22nd, 2007

In top dog, when a PDE5 inhibitor is administered on top of antihypertensive medicines, there are size additive reductions in BP that are similar to the step-down in BP that occurs with the PDE5 inhibitor alone with tadalafil soft tablets.

PDE-5 Inhibitor Monotherapy

Thursday, September 20th, 2007

Their findings indicated that daily viagra improved LUTS and erectile mathematical relation compared with medicine (P < .0001).
In gain, compared with vesper, sildenafil significantly reduced LUTS as assessed by the International Prostate Indication Debt (IPSS) quality-of-life doubtfulness (P < .0001) and the BPH Upshot Graduated table (BPHII) (P < .0001).

“The improvements in LUTS with no significant coin in peak urinary flow rate suggest that a new pathophysiology category may be needed to explain the aetiology of LUTS,” the researchers note in their sum-up.

They also compass point out that the improvements in IPSS were similar to those achieved with alpha-blockers.

Another reflexion by Claus Georg Roehrborn, MD, professor and chairman of the Section of Urology at the Educational institution of Texas SW Medical Nerve center in Dallas, and colleagues reported similar findings with the PDE-5 inhibitor tadalafil.

A sum of 281 men were randomized to receive tadalafil (5 mg for 6 weeks followed by dose escalation to 20 mg for 6 weeks) or medication for 12 weeks.
At both 6 weeks and 12 weeks, tadalafil was found to significantly improve IPSS, IPSS social rank of life, BPHII, and the LUTS Global Charge Topic compared with medication (P </= .008 for all).

Treating Lower Urinary System Symptoms

Sunday, September 16th, 2007

May 25, 2006 — Figure new studies presented here at the 2006 reference book social affair of the American Urological Chemical action help the use of phosphodiesterase-5 (PDE-5) inhibitors for the closure of lower urinary pathway symptoms (LUTS) formation to benign prostatic hyperplasia (BPH).

One of the studies evaluated sildenafil monotherapy, another evaluated tadalafil monotherapy, and the gear mechanism evaluated the operation of the letter 1-adrenergic mortal alfuzosin plus sildenafil.

Kevin T.
McVary, MD, companion professor of urology at Northwestern University’s Feinberg Schooltime of Medicinal drug in Stops, Illinois, and colleagues evaluated the efficacy of sildenafil monotherapy for the attention of men with erectile dysfunction and concomitant LUTS.
Patients (N = 366) were randomized to receive either viagra or medicine, taken each crepuscle or before sexual organic process.